• Impaired IS termination and enhanced CTL cytokine production intensity were distinct and synergistic HLH-driving mechanisms.

  • An IL-18/IFN-γ axis promoted RIPK1-dependent necroptotic cell death and HLH immunopathology, offering a new potential therapeutic target.

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening systemic hyperinflammatory syndrome arising in many contexts. Its underlying mechanisms are often unclear, but defective granule-mediated cytotoxicity (familial HLH) and excess interleukin-18 (IL-18; macrophage activation syndrome) provide clues. Mounting evidence suggests the causes of HLH converge on cytotoxic T lymphocyte (CTL) hyperactivation and interferon gamma (IFN-γ) overproduction. We refined an in vitro system to simultaneously quantify multiple parameters of the murine CTL immune synapse (IS). Even in haploinsufficiency, perforin deficiency prolonged IS duration and increased IFN-γ/tumor necrosis factor production. Similarly, both target cell immortalization and inhibition of apoptotic caspases impaired IS termination and increased cytokine production. Strong CTL activation, through T-cell receptor or IL-18 signaling, also increased IFN-γ secretion but accelerated target cell death. Impaired IS termination synergized with strong CTL activation in driving IFN-γ production. Visually, both typical and Prf1–/– CTL-IS terminated with apoptotic contraction. Serendipitously, we observed many IL-18–exposed CTL-IS terminated by target cell ballooning. Both IL-18–activated CTL and IFN-γ pretreatment caused up to half of target cells to die by receptor-interacting protein kinase 1 (RIPK1)–dependent necroptosis. In vivo, RIPK1 inhibition ameliorated virus-triggered HLH in Il18tg more than Prf1–/– mice. By quantifying CTL-IS duration, cytokine production, and mode of cell death, we modeled multiple HLH contributors and their interactions and identified 3 HLH mechanistic categories: impaired IS termination, intense CTL cytokine production, and inflammatory target cell death. Integrating the inputs and outcomes of a hyperinflammatory CTL-IS may provide a useful framework for understanding, predicting, or treating HLH in its many forms.

1.
Henter
JI
,
Sieni
E
,
Eriksson
J
, et al
.
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited
.
Blood
.
2024
;
144
(
22
):
2308
-
2318
.
2.
Ravelli
A
,
Minoia
F
,
Davì
S
, et al;
Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society
.
2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation collaborative initiative
.
Arthritis Rheumatol
.
2016
;
68
(
3
):
566
-
576
.
3.
Fardet
L
,
Galicier
L
,
Lambotte
O
, et al
.
Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome
.
Arthritis Rheumatol
.
2014
;
66
(
9
):
2613
-
2620
.
4.
Zoref-Lorenz
A
,
Murakami
J
,
Hofstetter
L
, et al
.
An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis
.
Blood
.
2022
;
139
(
7
):
1098
-
1110
.
5.
Canna
SW
,
Marsh
RA
.
Pediatric hemophagocytic lymphohistiocytosis
.
Blood
.
2020
;
135
(
16
):
1332
-
1343
.
6.
Shakoory
B
,
Geerlinks
A
,
Wilejto
M
, et al
.
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
.
Arthritis Rheumatol
.
2023
;
75
(
10
):
1714
-
1732
.
7.
Canna
SW
,
Cron
RQ
.
Highways to hell: mechanism-based management of cytokine storm syndromes
.
J Allergy Clin Immunol
.
2020
;
146
(
5
):
949
-
959
.
8.
Sanchez
EE
,
Tello-Lafoz
M
,
Guo
AJ
, et al
.
Apoptotic contraction drives target cell release by cytotoxic T cells
.
Nat Immunol
.
2023
;
24
(
9
):
1434
-
1442
.
9.
Turvey
SE
,
Biggs
CM
,
James
EL
,
Hildebrand
KJ
.
Should "primary immune disorder" replace "inborn error of immunity"? Names matter, but there is room for both
.
J Allergy Clin Immunol
.
2024
;
153
(
6
):
1546
-
1547
.
10.
Marsh
RA
,
Madden
L
,
Kitchen
BJ
, et al
.
XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease
.
Blood
.
2010
;
116
(
7
):
1079
-
1082
.
11.
Mauhin
W
,
Habarou
F
,
Gobin
S
, et al
.
Update on lysinuric protein intolerance, a multi-faceted disease retrospective cohort analysis from birth to adulthood
.
Orphanet J Rare Dis
.
2017
;
12
(
1
):
3
.
12.
Romberg
N
,
Vogel
TP
,
Canna
SW
.
NLRC4 inflammasomopathies
.
Curr Opin Allergy Clin Immunol
.
2017
;
17
(
6
):
398
-
404
.
13.
Landy
E
,
Carol
H
,
Ring
A
,
Canna
S
.
Biological and clinical roles of IL-18 in inflammatory diseases
.
Nat Rev Rheumatol
.
2024
;
20
(
1
):
33
-
47
.
14.
Fautrel
B
,
Mitrovic
S
,
De Matteis
A
, et al
.
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease
.
Ann Rheum Dis
.
2024
;
83
(
12
):
1614
-
1627
.
15.
Shamriz
O
,
Kumar
D
,
Shim
J
, et al
.
T cell-Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (HLH) occurs in non-Asians and is associated with a T cell activation state that is comparable to primary HLH [published correction appears in J Clin Immunol. 2021;41(8):1979]
.
J Clin Immunol
.
2021
;
41
(
7
):
1582
-
1596
.
16.
Daver
N
,
McClain
K
,
Allen
CE
, et al
.
A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults
.
Cancer
.
2017
;
123
(
17
):
3229
-
3240
.
17.
Hines
MR
,
Knight
TE
,
McNerney
KO
, et al
.
Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome
.
Transpl Cel Ther
.
2023
;
29
(
7
):
438.e1
-
438.e16
.
18.
Chaturvedi
V
,
Marsh
RA
,
Zoref-Lorenz
A
, et al
.
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis
.
Blood
.
2021
;
137
(
17
):
2337
-
2346
.
19.
Segal
JE
,
Daley
JD
,
Barnum
JL
, et al
.
Systemic and nodular hyperinflammation in a patient with refractory familial hemophagocytic lymphohistiocytosis 2
.
J Clin Immunol
.
2021
;
41
(
5
):
987
-
991
.
20.
De Matteis
A
,
Colucci
M
,
Rossi
MN
, et al
.
Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH
.
Blood
.
2022
;
140
(
3
):
262
-
273
.
21.
Nguyen
TH
,
Kumar
D
,
Prince
C
, et al
.
Frequency of HLA-DR(+)CD38(hi) T cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disorders
.
J Allergy Clin Immunol
.
2024
;
153
(
1
):
309
-
319
.
22.
Lin
H
,
Scull
BP
,
Goldberg
BR
, et al
.
IFN-gamma signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS
.
Blood Adv
.
2021
;
5
(
17
):
3457
-
3467
.
23.
Bracaglia
C
,
de Graaf
K
,
Pires Marafon
D
, et al
.
Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
.
Ann Rheum Dis
.
2017
;
76
(
1
):
166
-
172
.
24.
Jordan
MB
,
Hildeman
D
,
Kappler
J
,
Marrack
P
.
An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder
.
Blood
.
2004
;
104
(
3
):
735
-
743
.
25.
Jessen
B
,
Kögl
T
,
Sepulveda
FE
,
de Saint Basile
G
,
Aichele
P
,
Ehl
S
.
Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice
.
Frontiers Immunol
.
2013
;
4
:
448
.
26.
Terrell
CE
,
Jordan
MB
.
Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells
.
Blood
.
2013
;
121
(
26
):
5184
-
5191
.
27.
Jenkins
MR
,
Rudd-Schmidt
JA
,
Lopez
JA
, et al
.
Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time
.
J Exp Med
.
2015
;
212
(
3
):
307
-
317
.
28.
Rood
JE
,
Canna
SW
,
Weaver
LK
,
Tobias
JW
,
Behrens
EM
.
IL-10 distinguishes a unique population of activated, effector-like CD8(+) T cells in murine acute liver inflammation
.
J Leukoc Biol
.
2017
;
101
(
4
):
1037
-
1044
.
29.
Tsoukas
P
,
Rapp
E
,
Van Der Kraak
L
, et al
.
Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation
.
Blood
.
2020
;
136
(
19
):
2162
-
2174
.
30.
Landy
E
,
Varghese
J
,
Dang
V
,
Szymczak-Workman
A
,
Kane
LP
,
Canna
SW
.
Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation
.
Blood Adv
.
2023
;
7
(
22
):
6949
-
6963
.
31.
Zhang
M
,
Cron
RR
,
Chu
N
, et al
.
Role of DOCK8 in cytokine storm syndromes
.
J Allergy Clin Immunol
.
2025
;
155
(
3
):
1015
-
1026.e5
.
32.
Locatelli
F
,
Jordan
MB
,
Allen
C
, et al
.
Emapalumab in children with primary hemophagocytic lymphohistiocytosis
.
N Engl J Med
.
2020
;
382
(
19
):
1811
-
1822
.
33.
De Benedetti
F
,
Grom
AA
,
Brogan
PA
, et al
.
Efficacy and safety of emapalumab in macrophage activation syndrome
.
Ann Rheum Dis
.
2023
;
82
(
6
):
857
-
865
.
34.
Schuelke
MR
,
Bassiri
H
,
Behrens
EM
, et al
.
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients [published correction appears in Blood Adv. 2023;7(22):6829]
.
Blood Adv
.
2023
;
7
(
18
):
5603
-
5607
.
35.
Wang
W
,
Yuan
X
,
Yu
L
,
Pei
F
.
Emapalumab as a therapeutic intervention for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a case series
.
Medicine (Baltimore)
.
2024
;
103
(
39
):
e39880
.
36.
Zhang
Q
,
Zhao
YZ
,
Ma
HH
, et al
.
A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis
.
Blood
.
2022
;
139
(
24
):
3493
-
3504
.
37.
Hoshino
T
,
Kawase
Y
,
Okamoto
M
, et al
.
Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function
.
J Immunol
.
2001
;
166
(
12
):
7014
-
7018
.
38.
Takahashi
N
,
Duprez
L
,
Grootjans
S
, et al
.
Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models
.
Cell Death Dis
.
2012
;
3
(
11
):
e437
.
39.
Lim
SY
,
Davidson
SM
,
Mocanu
MM
,
Yellon
DM
,
Smith
CC
.
The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore
.
Cardiovasc Drugs Ther
.
2007
;
21
(
6
):
467
-
469
.
40.
Lopez
JA
,
Susanto
O
,
Jenkins
MR
, et al
.
Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack
.
Blood
.
2013
;
121
(
14
):
2659
-
2668
.
41.
Lopez
JA
,
Jenkins
MR
,
Rudd-Schmidt
JA
, et al
.
Rapid and unidirectional perforin pore delivery at the cytotoxic immune synapse
.
J Immunol
.
2013
;
191
(
5
):
2328
-
2334
.
42.
Gasmi
B
,
Kleiner
DE
.
Liver histology: diagnostic and prognostic features
.
Clin Liver Dis
.
2020
;
24
(
1
):
61
-
74
.
43.
Mostafavi
S
,
Yoshida
H
,
Moodley
D
, et al;
Immunological Genome Project Consortium
.
Parsing the interferon transcriptional network and its disease associations
.
Cell
.
2016
;
164
(
3
):
564
-
578
.
44.
Lykens
JE
,
Terrell
CE
,
Zoller
EE
,
Risma
K
,
Jordan
MB
.
Perforin is a critical physiologic regulator of T-cell activation
.
Blood
.
2011
;
118
(
3
):
618
-
626
.
45.
Ishii
K
,
Pouzolles
M
,
Chien
CD
, et al
.
Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients
.
J Clin Invest
.
2020
;
130
(
10
):
5425
-
5443
.
46.
Kaufman
KM
,
Linghu
B
,
Szustakowski
JD
, et al
.
Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis
.
Arthritis Rheumatol
.
2014
;
66
(
12
):
3486
-
3495
.
47.
Schulert
GS
,
Zhang
M
,
Fall
N
, et al
.
Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza
.
J Infect Dis
.
2016
;
213
(
7
):
1180
-
1188
.
48.
Rocco
JM
,
Laidlaw
E
,
Galindo
F
, et al
.
Mycobacterial immune reconstitution inflammatory syndrome in HIV is associated with protein-altering variants in hemophagocytic lymphohistiocytosis-related genes
.
J Infect Dis
.
2023
;
228
(
2
):
111
-
115
.
49.
Bloch
C
,
Jais
JP
,
Gil
M
, et al;
French HLH Study Group
.
Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants
.
J Allergy Clin Immunol
.
2024
;
153
(
1
):
256
-
264
.
50.
Correia Marques
M
,
Rubin
D
,
Shuldiner
EG
, et al;
INCHARGE Consortium
.
Enrichment of rare variants of hemophagocytic lymphohistiocytosis genes in systemic juvenile idiopathic arthritis
.
Arthritis Rheumatol
.
2024
;
76
(
10
):
1566
-
1572
.
51.
De Nardo
D
,
Kalvakolanu
DV
,
Latz
E
.
Immortalization of murine bone marrow-derived macrophages
.
Methods Mol Biol
.
2018
;
1784
:
35
-
49
.
52.
Agenès
F
,
Dangy
JP
,
Kirberg
J
.
T cell receptor contact to restricting MHC molecules is a prerequisite for peripheral interclonal T cell competition
.
J Exp Med
.
2008
;
205
(
12
):
2735
-
2743
.
53.
Jenkins
MR
,
Tsun
A
,
Stinchcombe
JC
,
Griffiths
GM
.
The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse
.
Immunity
.
2009
;
31
(
4
):
621
-
631
.
54.
Ritter
AT
,
Asano
Y
,
Stinchcombe
JC
, et al
.
Actin depletion initiates events leading to granule secretion at the immunological synapse
.
Immunity
.
2015
;
42
(
5
):
864
-
876
.
55.
Puglielli
MT
,
Zajac
AJ
,
van der Most
RG
, et al
.
In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb
.
J Virol
.
2001
;
75
(
11
):
5099
-
5107
.
56.
Weiss
ES
,
Girard-Guyonvarc'h
C
,
Holzinger
D
, et al
.
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
.
Blood
.
2018
;
131
(
13
):
1442
-
1455
.
57.
Yuan
J
,
Ofengeim
D
.
A guide to cell death pathways
.
Nat Rev Mol Cel Biol
.
2024
;
25
(
5
):
379
-
395
.
58.
Karki
R
,
Sharma
BR
,
Tuladhar
S
, et al
.
Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes
.
Cell
.
2021
;
184
(
1
):
149
-
168.e17
.
59.
Billiau
AD
,
Roskams
T
,
Van Damme-Lombaerts
R
,
Matthys
P
,
Wouters
C
.
Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages
.
Blood
.
2005
;
105
(
4
):
1648
-
1651
.
60.
Huang
Z
,
Brodeur
KE
,
Chen
L
, et al
.
Type I interferon signature and cycling lymphocytes in macrophage activation syndrome
.
J Clin Invest
.
2023
;
133
(
22
):
e165616
.
61.
Rocco
J
,
Manion
M
,
Laidlaw
E
, et al
. Immune profiles differentiate mycobacterial and KSHV triggered secondary hemophagocytic lymphohistiocytosis in people with advanced HIV [abstract]. Paper presented at.
International Cytokine & Interferon Society
;
23 October 2023; Athens, Greece
.
62.
Chapin
CA
,
Burn
T
,
Meijome
T
, et al
.
Indeterminate pediatric acute liver failure is uniquely characterized by a CD103(+) CD8(+) T-cell infiltrate
.
Hepatology
.
2018
;
68
(
3
):
1087
-
1100
.
63.
Schulert
GS
,
Canna
SW
.
Convergent pathways of the hyperferritinemic syndromes
.
Int Immunol
.
2018
;
30
(
5
):
195
-
203
.
64.
Noori
T
,
Rudd-Schmidt
JA
,
Kane
A
, et al
.
A cell-based functional assay that accurately links genotype to phenotype in familial HLH
.
Blood
.
2023
;
141
(
19
):
2330
-
2342
.
65.
Voskoboinik
I
,
Lacaze
P
,
Jang
HS
, et al
.
Prevalence and disease predisposition of p.A91V perforin in an aged population of European ancestry
.
Blood
.
2020
;
135
(
8
):
582
-
584
.
66.
Hadzic
N
,
Molnar
E
,
Height
S
, et al
.
High prevalence of hemophagocytic lymphohistiocytosis in acute liver failure of infancy
.
J Pediatr
.
2022
;
250
:
67
-
74.e61
.
67.
Hirami
Y
,
Nishimura
MF
,
Urata
T
, et al
.
Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma
.
J Clin Exp Hematop
.
2023
;
63
(
1
):
25
-
31
.
68.
Kanda
N
,
Yamaguchi
R
,
Yamamoto
Y
,
Matsumura
M
,
Hatakeyama
S
.
Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever
.
Sci Rep
.
2023
;
13
(
1
):
18784
.
69.
Yoon
SE
,
Eun
Y
,
Huh
K
, et al
.
A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study
.
Ann Hematol
.
2020
;
99
(
9
):
2095
-
2104
.
70.
Snow
AL
,
Marsh
RA
,
Krummey
SM
, et al
.
Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency
.
J Clin Invest
.
2009
;
119
(
10
):
2976
-
2989
.
71.
Sepulveda
FE
,
Maschalidi
S
,
Vosshenrich
CA
, et al
.
A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice
.
Blood
.
2015
;
125
(
9
):
1427
-
1434
.
72.
Krei
JM
,
Møller
HJ
,
Larsen
JB
.
The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome – a systematic review
.
Clin Exp Immunol
.
2021
;
203
(
2
):
174
-
182
.
73.
Davenport
AJ
,
Cross
RS
,
Watson
KA
, et al
.
Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity [published correction appears in Proc Natl Acad Sci U S A. 2019;116(22):11075-11076]
.
Proc Natl Acad Sci U S A
.
2018
;
115
(
9
):
E2068
-
E2076
.
74.
Taft
J
,
Markson
M
,
Legarda
D
, et al
.
Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death
.
Cell
.
2021
;
184
(
17
):
4447
-
4463.e20
.
75.
Degterev
A
,
Maki
JL
,
Yuan
J
.
Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase
.
Cell Death Differ
.
2013
;
20
(
2
):
366
.
76.
Taylor
MD
,
Burn
TN
,
Wherry
EJ
,
Behrens
EM
.
CD8 T cell memory increases immunopathology in the perforin-deficient model of hemophagocytic lymphohistiocytosis secondary to TNF-alpha
.
Immunohorizons
.
2018
;
2
(
2
):
67
-
73
.
You do not currently have access to this content.
Sign in via your Institution